Variant report
Variant | esv3333724 |
---|---|
Chromosome Location | chr3:145235923-145236091 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs575948609 | chr3:145235930-145235931 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs375330606 | chr3:145235934-145235935 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs374531328 | chr3:145235939-145235940 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs376895007 | chr3:145235951-145235952 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs143045592 | chr3:145235952-145235953 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs148188017 | chr3:145235963-145235964 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs201048505 | chr3:145236000-145236001 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs199917956 | chr3:145236001-145236002 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs368103157 | chr3:145236014-145236015 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs371949511 | chr3:145236016-145236017 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs199813251 | chr3:145236024-145236025 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs191525982 | chr3:145236029-145236030 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs201142488 | chr3:145236035-145236036 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs561619469 | chr3:145236041-145236042 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs375450785 | chr3:145236042-145236043 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183309694 | chr3:145236043-145236044 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs201036131 | chr3:145236057-145236058 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs377146489 | chr3:145236072-145236073 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs565915880 | chr3:145236073-145236074 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs569667407 | chr3:145236076-145236077 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs369916530 | chr3:145236079-145236080 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs374492900 | chr3:145236080-145236081 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs376415936 | chr3:145236082-145236083 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs116286452 | chr3:145236083-145236084 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs532052371 | chr3:145236087-145236088 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Colorectal cancer | 18645599 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Blepharophimosis-ptosis-epicanthus inversus syndrome | 22067867 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Autism | 18923514 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Autism | 21956041 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Breast cancer | 16608533 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:145224600-145237400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
2 | chr3:145232600-145236200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr3:145235200-145237800 | Enhancers | HepG2 | liver |